474958-87-7

Upstream product

• 153481-85-7 (4R,5S)-2,2-dimethyl-5-phenyl-[1,3]-dioxolane-4-carbaldehyde 
• 1006371-16-9 (4R,5S)-2,2-dimethyl-4-[(2R)-oxiran-2-yl]-5-phenyl-1,3-dioxolane 
• 1826-67-1 vinyl magnesium bromide 

Downstream Products

• 1006371-17-0 (1R)-1-[(4S,5S)-2,2-dimethyl-5-phenyl-1,3-dioxolan-4-yl]but-3-en-1-yl prop-2-enoate 
• 474958-89-9 (6R)-6-[(4S,5S)-2,2-dimethyl-5-phenyl-1,3-dioxolan-4-yl]-5,6-dihydro-2H-pyran-2-one 
• 146236-73-9 (6R)-6-[(1R,2S)-1,2-dihydroxy-2-phenylethyl]-5,6-dihydro-2H-pyran-2-one 
• 136685-37-5 (1R,5R,7S,8S)-8-hydroxy-7-phenyl-2,6-dioxa-bicyclo-[3.3.1]-nonan-3-one 

Relevant academic research and scientific papers

Highly diastereoselective total syntheses of (+)-7-epigoniodiol, (-)-8-epigoniodiol, and (+)-9-deoxygoniopypyrone

An expedient concise total synthesis of (+)-7-epigoniodiol, (-)-8-epigoniodiol, and (+)-9-deoxygoniopypyrone is accomplished. The key transformations include a catalytic hydroxylation and base-mediated N-(acetyl)oxazolidinone addition reactions, which cou

Stereoselective total synthesis of bioactive styryllactones: 9-Deoxygoniopypyrone, goniopypyrone and 7-epi-goniofufurone

Stereoselective synthesis of the bioactive styryllactones (+)-9-deoxygoniopypyrone, (+)-goniopypyrone and (+)-7-epi-goniofufurone has been achieved from D-(-)-tartaric acid. The key step involves the elaboration of a trihydroxy ester to the title compound